LENZ Therapeutics, Inc. (LENZ)
3.01
-0.45
(-13.01%)
USD |
NASDAQ |
Nov 05, 16:00
3.18
+0.17
(+5.65%)
After-Hours: 06:38
LENZ Therapeutics Net Income (TTM) : -140.27M for Sept. 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -140.27M |
| June 30, 2026 | -126.00M |
| March 31, 2026 | -109.00M |
| December 31, 2025 | -82.13M |
| September 30, 2025 | -58.88M |
| June 30, 2025 | -52.40M |
| March 31, 2025 | -47.74M |
| December 31, 2024 | -49.77M |
| September 30, 2024 | -60.81M |
| June 30, 2024 | -69.47M |
| March 31, 2024 | -73.95M |
| December 31, 2023 | -69.97M |
| Date | Value |
|---|---|
| September 30, 2023 | -70.88M |
| June 30, 2023 | -76.68M |
| March 31, 2023 | -88.61M |
| December 31, 2022 | -102.08M |
| September 30, 2022 | -96.42M |
| June 30, 2022 | -86.33M |
| March 31, 2022 | -77.20M |
| December 31, 2021 | -70.76M |
| September 30, 2021 | -115.37M |
| June 30, 2021 | -104.16M |
| March 31, 2021 | -87.94M |
| December 31, 2020 | -68.37M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Impact BioMedical, Inc. | 0.776M |
| EyePoint, Inc. | -306.64M |
| Ligand Pharmaceuticals, Inc. | 51.46M |
| Enveric Biosciences, Inc. | -8.729M |
| Indivior Pharmaceuticals, Inc. (DELISTED) | 450.00M |